Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Uncategorized

Qualigen Therapeutics Q4 EPS $(0.13), Sales $1.90M

Qualigen Therapeutics (NASDAQ:QLGN) reported quarterly losses of $(0.13) per share. The company reported $1.90 million in sales this quarter.

byBenzinga Newsdesk

May 14, 2021

1 minute read

Qualigen Therapeutics (NASDAQ:QLGN) reported quarterly losses of $(0.13) per share. The company reported $1.90 million in sales this quarter.

Evercore ISI Group Maintains Outperform on Cerence, Raises Price Target to $150

By Benzinga Newsdesk

Today, 8:21 PM

Evercore ISI Group analyst Chris McNally maintains Cerence (NASDAQ:CRNC) with a Outperform and raises the price target from $125 to $150.

CRNC

Vanda Pharmaceuticals Q3 EPS $0.06 Misses $0.09 Estimate, Sales $65.32M Miss $71.00M Estimate

By Benzinga Newsdesk

Today, 8:21 PM

Vanda Pharmaceuticals (NASDAQ:VNDA) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $0.09 by 33.33 percent. This is a 57.14 percent decrease over earnings of $0.14 per share

VNDA

Barclays Maintains Overweight on Warner Music Group, Raises Price Target to $35

By Benzinga Newsdesk

Today, 8:21 PM

Barclays analyst Kannan Venkateshwar maintains Warner Music Group (NASDAQ:WMG) with a Overweight and raises the price target from $30 to $35.

WMG

Wedbush Initiates Coverage On Academy Sports with Outperform Rating, Announces Price Target of $54

By Benzinga Newsdesk

Today, 8:21 PM

Wedbush analyst Seth Basham initiates coverage on Academy Sports (NASDAQ:ASO) with a Outperform rating and announces Price Target of $54.

ASO

Qualigen Therapeutics Q4 EPS $(0.13), Sales $1.90M

Related Posts

Evercore ISI Group Maintains Outperform on Cerence, Raises Price Target to $150

Vanda Pharmaceuticals Q3 EPS $0.06 Misses $0.09 Estimate, Sales $65.32M Miss $71.00M Estimate

Barclays Maintains Overweight on Warner Music Group, Raises Price Target to $35

Wedbush Initiates Coverage On Academy Sports with Outperform Rating, Announces Price Target of $54